214 related articles for article (PubMed ID: 23435427)
1. HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome.
Wardwell-Ozgo J; Dogruluk T; Gifford A; Zhang Y; Heffernan TP; van Doorn R; Creighton CJ; Chin L; Scott KL
Oncogene; 2014 Feb; 33(8):1017-26. PubMed ID: 23435427
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.
Zha TZ; Hu BS; Yu HF; Tan YF; Zhang Y; Zhang K
Tumour Biol; 2012 Dec; 33(6):2125-34. PubMed ID: 22864671
[TBL] [Abstract][Full Text] [Related]
3. Hoxa1 targets signaling pathways during neural differentiation of ES cells and mouse embryogenesis.
De Kumar B; Parker HJ; Paulson A; Parrish ME; Zeitlinger J; Krumlauf R
Dev Biol; 2017 Dec; 432(1):151-164. PubMed ID: 28982536
[TBL] [Abstract][Full Text] [Related]
4. HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells.
Wang H; Liu G; Shen D; Ye H; Huang J; Jiao L; Sun Y
Oncol Rep; 2015 Sep; 34(3):1203-10. PubMed ID: 26135141
[TBL] [Abstract][Full Text] [Related]
5. Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo.
Labelle-Côté M; Dusseault J; Ismaïl S; Picard-Cloutier A; Siegel PM; Larose L
BMC Cancer; 2011 Oct; 11():443. PubMed ID: 21992144
[TBL] [Abstract][Full Text] [Related]
6. HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells.
Mohankumar KM; Xu XQ; Zhu T; Kannan N; Miller LD; Liu ET; Gluckman PD; Sukumar S; Emerald BS; Lobie PE
Oncogene; 2007 Jun; 26(27):3998-4008. PubMed ID: 17213808
[TBL] [Abstract][Full Text] [Related]
7. EMT-associated factors promote invasive properties of uveal melanoma cells.
Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
[TBL] [Abstract][Full Text] [Related]
8. A PGC1α-mediated transcriptional axis suppresses melanoma metastasis.
Luo C; Lim JH; Lee Y; Granter SR; Thomas A; Vazquez F; Widlund HR; Puigserver P
Nature; 2016 Sep; 537(7620):422-426. PubMed ID: 27580028
[TBL] [Abstract][Full Text] [Related]
9. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-99a-5p alleviates atherosclerosis via regulating Homeobox A1.
Han Z; Guan Y; Liu B; Lin Y; Yan Y; Wang H; Wang H; Jing B
Life Sci; 2019 Sep; 232():116664. PubMed ID: 31325426
[TBL] [Abstract][Full Text] [Related]
11. MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer.
Zhang L; Liu XL; Yuan Z; Cui J; Zhang H
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4663-4672. PubMed ID: 31210292
[TBL] [Abstract][Full Text] [Related]
12. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.
Yuan C; Zhu X; Han Y; Song C; Liu C; Lu S; Zhang M; Yu F; Peng Z; Zhou C
J Exp Clin Cancer Res; 2016 Jan; 35():15. PubMed ID: 26791264
[TBL] [Abstract][Full Text] [Related]
13. A gene expression signature of invasive potential in metastatic melanoma cells.
Jeffs AR; Glover AC; Slobbe LJ; Wang L; He S; Hazlett JA; Awasthi A; Woolley AG; Marshall ES; Joseph WR; Print CG; Baguley BC; Eccles MR
PLoS One; 2009 Dec; 4(12):e8461. PubMed ID: 20041153
[TBL] [Abstract][Full Text] [Related]
14. Role of PLZF in melanoma progression.
Felicetti F; Bottero L; Felli N; Mattia G; Labbaye C; Alvino E; Peschle C; Colombo MP; Carè A
Oncogene; 2004 Jun; 23(26):4567-76. PubMed ID: 15077196
[TBL] [Abstract][Full Text] [Related]
15. HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis.
Bitu CC; Destro MF; Carrera M; da Silva SD; Graner E; Kowalski LP; Soares FA; Coletta RD
BMC Cancer; 2012 Apr; 12():146. PubMed ID: 22498108
[TBL] [Abstract][Full Text] [Related]
16. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression.
Ryu B; Kim DS; Deluca AM; Alani RM
PLoS One; 2007 Jul; 2(7):e594. PubMed ID: 17611626
[TBL] [Abstract][Full Text] [Related]
18. Targeting invasive properties of melanoma cells.
Arozarena I; Wellbrock C
FEBS J; 2017 Jul; 284(14):2148-2162. PubMed ID: 28196297
[TBL] [Abstract][Full Text] [Related]
19. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.
Goodall J; Carreira S; Denat L; Kobi D; Davidson I; Nuciforo P; Sturm RA; Larue L; Goding CR
Cancer Res; 2008 Oct; 68(19):7788-94. PubMed ID: 18829533
[TBL] [Abstract][Full Text] [Related]
20. Differences in gene expression between wild type and Hoxa1 knockout embryonic stem cells after retinoic acid treatment or leukemia inhibitory factor (LIF) removal.
Martinez-Ceballos E; Chambon P; Gudas LJ
J Biol Chem; 2005 Apr; 280(16):16484-98. PubMed ID: 15722554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
